Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1986 2
1987 3
1988 3
1989 3
1990 4
1991 2
1992 2
1993 1
1995 2
1996 1
1997 5
1998 4
1999 2
2000 8
2001 5
2002 2
2003 5
2004 7
2005 7
2006 5
2007 7
2008 10
2009 7
2010 5
2011 8
2012 7
2013 10
2014 7
2015 13
2016 3
2017 4
2018 3
2019 4
2020 5
2021 2
2023 4
2024 3
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Results by year

Filters applied: . Clear all
Page 1
Deubiquitinating enzymes as oncotargets.
McClurg UL, Robson CN. McClurg UL, et al. Among authors: robson cn. Oncotarget. 2015;6(12):9657-68. doi: 10.18632/oncotarget.3922. Oncotarget. 2015. PMID: 25962961 Free PMC article. Review.
Cellular functions of TIP60.
Sapountzi V, Logan IR, Robson CN. Sapountzi V, et al. Among authors: robson cn. Int J Biochem Cell Biol. 2006;38(9):1496-509. doi: 10.1016/j.biocel.2006.03.003. Epub 2006 Mar 28. Int J Biochem Cell Biol. 2006. PMID: 16698308 Review.
Engineering prostate cancer in vitro: what does it take?
Buskin A, Scott E, Nelson R, Gaughan L, Robson CN, Heer R, Hepburn AC. Buskin A, et al. Among authors: robson cn. Oncogene. 2023 Aug;42(32):2417-2427. doi: 10.1038/s41388-023-02776-6. Epub 2023 Jul 12. Oncogene. 2023. PMID: 37438470 Free PMC article. Review.
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.
Garnham R, Geh D, Nelson R, Ramon-Gil E, Wilson L, Schmidt EN, Walker L, Adamson B, Buskin A, Hepburn AC, Hodgson K, Kendall H, Frame FM, Maitland N, Coffey K, Strand DW, Robson CN, Elliott DJ, Heer R, Macauley M, Munkley J, Gaughan L, Leslie J, Scott E. Garnham R, et al. Among authors: robson cn. Commun Biol. 2024 Mar 6;7(1):276. doi: 10.1038/s42003-024-05924-0. Commun Biol. 2024. PMID: 38448753 Free PMC article.
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel.
Fitzpatrick JM, Bellmunt J, Fizazi K, Heidenreich A, Sternberg CN, Tombal B, Alcaraz A, Bahl A, Bracarda S, Di Lorenzo G, Efstathiou E, Finn SP, Fosså S, Gillessen S, Kellokumpu-Lehtinen PL, Lecouvet FE, Oudard S, de Reijke TM, Robson CN, De Santis M, Seruga B, de Wit R. Fitzpatrick JM, et al. Among authors: robson cn. Eur J Cancer. 2014 Jun;50(9):1617-27. doi: 10.1016/j.ejca.2014.03.010. Epub 2014 Apr 3. Eur J Cancer. 2014. PMID: 24703899 Free article.
166 results